What is D E Hokanson?
D. E. Hokanson, Inc. is a distinguished entity in the medical device sector, focusing on the design and manufacturing of advanced instruments and accessories tailored for the vascular health market. With a legacy spanning over four decades, the company has cemented its reputation for delivering reliable, durable, and accurate non-invasive vascular assessment tools, all produced domestically in the USA. Their comprehensive product line, which includes sophisticated vascular exams and diagnostic tools, plays a critical role in the management of prevalent conditions such as Peripheral Artery Disease. Hokanson's unwavering commitment to superior quality is further evidenced by a robust 5-year warranty offered on all its instruments, serving vascular specialists, physicians, researchers, and patients alike.
How much funding has D E Hokanson raised?
D E Hokanson has raised a total of $314K across 2 funding rounds:
Debt
$150K
Debt
$164K
Debt (2020): $150K with participation from PPP
Debt (2021): $164K led by PPP
Key Investors in D E Hokanson
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for D E Hokanson?
The recent strategic investment in D E Hokanson signals a pivotal moment for the company, likely enabling accelerated expansion and innovation within the vascular health technology space. As a company with a long-standing history and a focus on high-quality, USA-made diagnostic tools, this capital infusion is expected to bolster its market position and potentially drive the development of next-generation vascular assessment technologies. This late-stage funding suggests a strategic focus on scaling operations, enhancing research and development, and broadening market reach to meet the growing demands in vascular care.
See full D E Hokanson company page
